We first used a tissue microarray to detect IL-17+ cells and evaluate the expression of the HSCs activation biomarker actin alpha 2 smooth muscle aorta (ACTA2, also known as α-SMA) in HCC tissues. This evidence concerns the gene ACTA2 and hepatocellular carcinoma.